Capital Analysts, LLC Boston Scientific Corp Transaction History

Capital Analysts, LLC

  • $2.68 Billion
  • Q1 2025

A detailed history of Capital Analysts, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Capital Analysts, LLC holds 49,459 shares of BSX stock, worth $5.17 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
49,459
Previous 48,637 1.69%
Holding current value
$5.17 Million
Previous $4.34 Million 14.85%
% of portfolio
0.19%
Previous 0.17%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
BUY
$89.38 - $106.18 $73,470 - $87,279
822 Added 1.69%
49,459 $4.99 Million
Q4 2024

Feb 14, 2025
BUY
$83.62 - $91.5 $60,875 - $66,612
728 Added 1.52%
48,637 $4.34 Million
Q3 2024

Nov 13, 2024
BUY
$72.96 - $84.0 $269,733 - $310,548
3,697 Added 8.36%
47,909 $4.01 Million
Q2 2024

Aug 14, 2024
BUY
$67.33 - $77.71 $136,477 - $157,518
2,027 Added 4.81%
44,212 $3.41 Million
Q1 2024

May 14, 2024
BUY
$57.6 - $68.62 $56,102 - $66,835
974 Added 2.36%
42,185 $2.89 Million
Q4 2023

Jan 30, 2024
BUY
$48.64 - $57.81 $42,219 - $50,179
868 Added 2.15%
41,211 $2.38 Million
Q3 2023

Nov 13, 2023
BUY
$50.19 - $54.68 $15,157 - $16,513
302 Added 0.75%
40,343 $2.13 Million
Q2 2023

Aug 11, 2023
SELL
$49.72 - $54.64 $31,124 - $34,204
-626 Reduced 1.54%
40,041 $2.17 Million
Q1 2023

May 05, 2023
SELL
$45.09 - $50.03 $584,095 - $648,088
-12,954 Reduced 24.16%
40,667 $2.04 Million
Q4 2022

Feb 08, 2023
SELL
$39.56 - $47.22 $71,564 - $85,420
-1,809 Reduced 3.26%
53,621 $2.48 Million
Q3 2022

Nov 14, 2022
SELL
$36.71 - $109.66 $10,866 - $32,459
-296 Reduced 0.53%
55,430 $2.15 Million
Q2 2022

Aug 12, 2022
SELL
$35.24 - $47.1 $12,334 - $16,485
-350 Reduced 0.62%
55,726 $2.08 Million
Q1 2022

May 12, 2022
BUY
$40.9 - $45.1 $69,284 - $76,399
1,694 Added 3.12%
56,076 $2.48 Million
Q4 2021

Feb 10, 2022
BUY
$38.07 - $44.87 $43,209 - $50,927
1,135 Added 2.13%
54,382 $2.31 Million
Q3 2021

Nov 04, 2021
BUY
$41.23 - $45.88 $86,459 - $96,210
2,097 Added 4.1%
53,247 $2.31 Million
Q2 2021

Aug 05, 2021
BUY
$38.58 - $44.24 $458,021 - $525,217
11,872 Added 30.23%
51,150 $2.19 Million
Q1 2021

May 17, 2021
BUY
$35.27 - $39.67 $167,920 - $188,868
4,761 Added 13.79%
39,278 $1.52 Million
Q4 2020

Feb 16, 2021
BUY
$33.15 - $41.97 $131,903 - $166,998
3,979 Added 13.03%
34,517 $1.24 Million
Q3 2020

Nov 12, 2020
BUY
$34.44 - $42.23 $82,759 - $101,478
2,403 Added 8.54%
30,538 $1.17 Million
Q2 2020

Aug 07, 2020
BUY
$30.19 - $39.11 $1,117 - $1,447
37 Added 0.13%
28,135 $988,000
Q1 2020

May 08, 2020
SELL
$25.83 - $45.71 $14,438 - $25,551
-559 Reduced 1.95%
28,098 $917,000
Q4 2019

Feb 12, 2020
BUY
$37.87 - $45.37 $52,677 - $63,109
1,391 Added 5.1%
28,657 $1.3 Million
Q3 2019

Nov 12, 2019
BUY
$40.31 - $43.45 $5,925 - $6,387
147 Added 0.54%
27,266 $1.11 Million
Q2 2019

Aug 13, 2019
SELL
$34.91 - $42.98 $56,030 - $68,982
-1,605 Reduced 5.59%
27,119 $1.17 Million
Q1 2019

May 13, 2019
SELL
$32.91 - $40.75 $293,952 - $363,979
-8,932 Reduced 23.72%
28,724 $1.1 Million
Q4 2018

Feb 13, 2019
SELL
$31.73 - $39.04 $126,666 - $155,847
-3,992 Reduced 9.59%
37,656 $1.33 Million
Q3 2018

Nov 07, 2018
BUY
$32.83 - $38.63 $22,685 - $26,693
691 Added 1.69%
41,648 $0
Q2 2018

Aug 03, 2018
SELL
$26.84 - $34.32 $2,039 - $2,608
-76 Reduced 0.19%
40,957 $0
Q1 2018

May 14, 2018
BUY
$25.2 - $28.54 $58,514 - $66,269
2,322 Added 6.0%
41,033 $1.12 Million
Q4 2017

Feb 14, 2018
BUY
$24.79 - $29.8 $957,166 - $1.15 Million
38,611 Added 38611.0%
38,711 $960,000
Q4 2017

Feb 12, 2018
BUY
$24.79 - $29.8 $2,479 - $2,980
100
100 $10,000

Others Institutions Holding BSX

# of Institutions
1,831
Shares Held
1.21B
Call Options Held
9.66M
Put Options Held
6.98M
View Full List

About BOSTON SCIENTIFIC CORP

BSX Quotes by TradingView
  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $150B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Capital Analysts, LLC Portfolio

Follow Capital Analysts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Analysts, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email